HOVNANIAN ENTERPRISES, INC.

HOV

CIK 0000357294 · Quarterly mode · latest period FY2026 (Q4) (ending 2026-01-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q4)

Revenue
$632M
↓-6.2% -$42Mvs FY2025 (Q4)
Operating Income
$597M
↓-8.2% -$53Mvs FY2025 (Q4)
Net Income
$21M
↓-26.0% -$7Mvs FY2025 (Q4)
Gross Profit
$632M
↓-6.2% -$42Mvs FY2025 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
20/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    46D/E 1.08 (under 0.5 = conservative)
  • Efficiency
    72Asset Turnover 1.14x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -6.2% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project HOV's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 29.3%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$804.25
Total enterprise IV
$5.54B
Diluted shares
0.01B
Terminal PV
$4.30B (78% of total)
Year-5 FCF
$507M
YearProjected FCFDiscounted PV
+1$208M$189M
+2$260M$215M
+3$325M$244M
+4$406M$277M
+5$507M$315M
Terminal$6.93B$4.30B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$27M
investment in PP&E
Dividends paid (TTM)
$8M
cash returned to holders
Stock buybacks (TTM)
$21M
share count reduction
Stock-based comp (TTM)
$15M
non-cash dilution

Balance sheet · 2026-01-31

latest filed snapshot
Total assets
$2.73B
everything owned
Total liabilities
$1.90B
everything owed
Stockholders' equity
$836M
shareholder claim
Net debt
$679M
LT debt minus cash

Recent performance · 67 quarters

Revenue↓-6.2% -$42M
$632M
Net Income↓-26.0% -$7M
$21M
Free Cash Flow↑+321.8% +$192M
$132M

Drill down